Advanced search
Publication Cover
Emerging Microbes & Infections Volume 10, 2021 - Issue 1
Submit an article Journal homepage
7,433
Views
26
CrossRef citations to date
0
Altmetric
Coronaviruses

Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial

Yuyi Liaoa Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, People’s Republic of ChinaView further author information
,
Yuan Lia Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, People’s Republic of ChinaView further author information
,
Rongjuan Peid Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of ChinaView further author information
,
Xin Fangc National Institutes for Food and Drug Control, Beijing, People’s Republic of ChinaView further author information
,
Peiyu Zenge Gaozhou Center for Disease Control and Prevention, Maoming, People’s Republic of ChinaView further author information
,
Renfeng Fana Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, People’s Republic of ChinaView further author information
,
Zhiqiang Oua Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, People’s Republic of ChinaView further author information
,
Jinglong Denge Gaozhou Center for Disease Control and Prevention, Maoming, People’s Republic of ChinaView further author information
,
Jian Zhoue Gaozhou Center for Disease Control and Prevention, Maoming, People’s Republic of ChinaView further author information
,
Wuxiang Guand Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of ChinaView further author information
,
Yuanqin Mind Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of ChinaView further author information
,
Fei Dengd Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of ChinaView further author information
,
Hua Pengg Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information
,
Zheng Zhangh Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People’s Hospital, Shenzhen, People’s Republic of ChinaView further author information
,
Chunyan Fengf LivzonBio Inc., Zhuhai, People’s Republic of ChinaView further author information
,
Baobao Xinf LivzonBio Inc., Zhuhai, People’s Republic of ChinaView further author information
,
Jianfeng Heb Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Zhongyu Huc National Institutes for Food and Drug Control, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Jikai Zhanga Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1589-1597 | Received 11 Jun 2021, Accepted 29 Jun 2021, Published online: 12 Aug 2021

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.